Research Progress on the Roles of Formononetin in Protecting Organ Injury and Promoting Regeneration and Repair
DOI:
https://doi.org/10.62767/jecacm603.3920Keywords:
Formononetin, multi-organ injuries, regeneration and repairAbstract
Formononetin (FMN) is a kind of flavonoid compound extracted from Astragalus membranaceus, Radix Puerariae and other plants. Extensive research has demonstrated that FMN possesses various biological activities, including anti-tumor, antioxidant, anti-inflammatory, immunomodulatory, estrogen-like and other biological activities, indicating a broad application prospect in many fields, such as tumor, osteoporosis, diabetes, cardiovascular and cerebrovascular diseases, and perimenopausal syndrome. Recent studies have extensively investigated the roles of FMN in different organ injuries and the regeneration and repair of these organs. And found that it has protective and regenerative repair effects on multiple organ injuries, including the hematopoietic immune system, cardiovascular system, nervous system, digestive system, respiratory system, urogenital system, and skeletal system. This study reviewed the impact and mechanism of FMN in the repair of multi-organ injuries, providing a theoretical basis for further elucidating the medicinal value of FMN and guiding its rational development and application.
References
Bai ZG, Zhu YM, Shi NN. Evidence-based research of the indicator system for evaluating the application effect of TCM standards. Guidelines and Standards in Chinese Medicine 2024; 2(4): 131-140.
Xin M, Wang Y, Ren Qy, et al. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro. Biomedicine & Pharmacotherapy 2019; 109: 2084-2089.
Yu XY, Gao F, Li W, et al. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 2020; 39(1): 1-17.
Wang Ws, Zhao CS. Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR‐542‐5p. The Kaohsiung Journal of Medical Sciences 2021; 37(3): 215-225.
Zhang BH, Hao ZW, Zhou WL, et al. Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPARγ signaling based on network pharmacology and experimental validation. Bioengineered 2021; 12(1): 4887-4898.
Liu QY, Zou YF, Li Y. Mechanism investigation of Pueraria-extracted formononetin on Alzheimer's Disease. Journal of Wuhan Polytechnic University 2024; 43(04): 23-32+48.
Fu XX, Qin TT, Yu JY, et al. Formononetin ameliorates cognitive disorder via PGC-1α pathway in neuroinflammation conditions in high-fat diet-induced mice. CNS & Neurological Disorders-Drug Targets 2019; 18(7): 566-577.
Gao ZS, Zhang CJ, Xia N, et al. Corrigendum to ‘Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy’ [Acta Biomaterialia 126 (2021) 211–223]. Acta Biomaterialia 2022; 140: 745-746.
Chen X, Wu R, Li L, et al. Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. Immunity 2023; 56(2): 336-352. e9.
Liu S. TLR4/NF-ĸB-mediated formononetin on the immune regulation of mouse peritoneal macrophages and KCs cells. Gansu Agricultural University 2021.
Zhang YP, Deng K, Jia N, et al. The Effect of Formononetin on the Immune Function in Immunosuppressed Mice. Chinese Animal Husbandry and Veterinary Medicine 2020; 47(03): 922-30.
Lu R, Wang S, Wang B. Immune activation effects of four traditional Chinese medicine monomers on antigen-presenting cells. Journal of Precision Medicine 2022; 37(04): 311-315+321.
Wang XH, Wang L, Xiao LJ, et al. Formononetin inhibits benign prostatic hyperplasia through estrogen receptors. Journal of Chinese Pharmaceutical Sciences 2024; 33(03): 216-229.
Wang JC, Wang L, Qin AP, et al. Improvement of formononetin on cognitive dysfunction in diabetic mice. Chinese Journal of Clinical Rational Drug Use 2022; 09: 1-5+9.
LI SQ, WU GX, LIU YL, et al. Research Progress on Pharmacological Effects and Mechanisms of Formononetin. Modern Chinese Medicine 2024;26(09): 1608-1617.
Lan HX, Qiu W, Wu J, et al. Formononetin reverses Treg/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K/Akt signaling pathway. Chinese Medicine 2024; 19(1): 55.
Mao TT, Bai H, Jia N. Effects of Formonetin on Mucosa Immunity Function in Small Intestinal of Immunosuppressive Mice. Chinese Journal of Animal Nutrition 2022; 34(04): 2712-20.
Kojima H, Takeda Y, Muromoto R, et al. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. Toxicology 2015; 329: 32-39.
Ma CR, Xia RL, Yang S, et al. Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/- mice. Theranostics 2020; 10(3): 1090-1106.
He Y, Cai YD, Wei DL, et al. Elucidating the mechanisms of formononetin in modulating atherosclerotic plaque formation in ApoE-/- mice. BMC Cardiovascular Disorders; 2024, 24(1): 121.
Wang DS, Yan LY, Yang DZ, et al. Formononetin ameliorates myocardial ischemia/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway. Biochemical and Biophysical Research Communications 2020; 525(3): 759-766.
Tang S, Ye JX, Li RY, et al. Formononetin attenuates myocardial ischemia/reperfusion injury by regulating neutrophil extracellular traps formation and platelet activation via platelet CD36. Phytomedicine 2025; 141: 156736.
Yang Y, Huang T, Zhang HL, et al. Formononetin improves cardiac function and depressive behaviours in myocardial infarction with depression by targeting GSK-3β to regulate macrophage/microglial polarization. Phytomedicine 2023; 109: 154602.
Xu H, Zhang XQ, Huang LM, et al. Formononetin improves heart failure with preserved ejection fraction in mice by activating the PPARα/PGC-1 pathway. Traditional Medicine Research 2024; 9(4): 20.
Qi YY, Xue SY, Chen WJ, et al. Formononetin regulates dilated cardiomyopathy-mediated heart failure in rats via HSP90/Akt cardiomyocyte apoptosis and mechanism. Journal of Xi'an Jiaotong University (Medical Sciences) 2023; 44(05): 794-801.
Li XY, Zhang W, Cao QT, et al. Mitochondrial dysfunction in fibrotic diseases. Cell Death Discovery 2020; 6(1): 80.
Qian L, Xu H, Yuan RQ, et al. Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction. Biomedicine & Pharmacotherapy 2024; 170: 116000.
Arjmand S, Ilaghi M, Sisakht AK, et al. Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic Clin Pharmacol Toxicol 2024; 135(2): 115-132.
Ma XY, Wang JJ. Formononetin: a pathway to protect neurons. Frontiers in Integrative Neuroscience 2022; 16: 908378.
Wu QL, Cheng YQ, Liu AJ, et al. Formononetin recovered injured nerve functions by enhancing synaptic plasticity in ischemic stroke rats. Biochemical and Biophysical Research Communications 2020; 525(1): 67-72.
Chen J, Cai YD, Wei DL, et al. Formononetin inhibits neuroinflammation in BV2 microglia induced by glucose and oxygen deprivation reperfusion through TLR4/NF-κB signaling pathway. Brain Research 2024; 1845: 149218.
Wei DL, Wang M, Wang WX, et al. Protective effects of formononetin against oxygen-glucose deprivation reperfusion injury in BV2 microglia and associated mechanism. Journal of Chongqing Medical University 2025; 50(02): 244-249.
Gu Y, Chen X, Fu SP, et al. Astragali Radix isoflavones synergistically alleviate cerebral ischemia and reperfusion injury via activating estrogen receptor-PI3K-Akt signaling pathway. Frontiers in Pharmacology 2021; 12: 533028.
Zou XR, Xu L. Protective Effects and Mechanism Study of Formononetin on Cerebral Ischemia-reperfusion Injury in Rats. Chinese Journal of Modern Applied Pharmacy 2018; 35(06): 855-858.
Yu L, Wang M, Wang WX, et al. The effect of formononetin on the neuron cell damage of oxygen-glucose deprivation/reoxygenation was studied based on the PARP1 signaling pathway. Acta Universitatis Medicinalis Anhui 2024; 59(02): 207-211.
Li YN, Li SB, Bai Y, et al. Sodium formononetin-3'-sulphonate alleviates cerebral ischemia-reperfusion injury via regulating mitochondrial apoptosis pathway. Chinese herbal medicine 2024; 55(11): 3759-3767.
Lin ZH, Wang SY, Chen LL, et al. Methylene Blue Mitigates Acute Neuroinflammation after Spinal Cord Injury through Inhibiting NLRP3 Inflammasome Activation in Microglia. Frontiers in Cellular Neuroscience 2017; 11: 391.
Fu HP, Li MD, Huan YQ, et al. Formononetin inhibits microglial inflammatory response and contributes to spinal cord injury repair by targeting the EGFR/MAPK pathway. Immunological Investigations 2023; 52(4): 399-414.
Bruner LP, White AM, Proksell S. Inflamma‐ tory bowel disease. Primary Care 2023; 50(3): 411-427.
Zhang J, Cen L, Zhang XF, et al. MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biology 2022; 56: 102469.
Li T, Zou QP, Mao ZW, et al. Therapeutic effect of flavonoids from Desmodium triflorum on an ulcerative colitis mouse model and the influence on intestinal flora. Chinese Journal of Comparative Medicine 2022; 32(04): 29-38.
Wu DC, Wu KY, Zhu QT, et al. Formononetin administration ameliorates dextran sulfate sodium-induced acute colitis by inhibiting NLRP3 inflammasome signaling pathway. Mediators of Inflammation 2018; 2018: 3048532.
Yang J, Sha XW, Wu D, et al. Formononetin alleviates acute pancreatitis by reducing oxidative stress and modulating intestinal barrier. Chinese Medicine 2023; 18(1): 78.
Xie D, Liu YY, Li ZX, et al. Effects of formononetin on the apoptosis of intestinal epithelial cells in rats with inflammatory bowel disease by regulating the Hippo/YAP signaling pathway. China Pharmacy 2024; 35(13): 1564-1569.
Wang Y, Zhao HL, Li X, et al. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy. The Journal of Nutritional Biochemistry 2019; 73: 108214.
Li P, Peng L, Wang Y, et al. The application of formononetin in the treatment of non-alcoholic fatty liver disease: CN110090209A [P]. 2019-08-06.
Liao JB, Xue XH, Wang N, et al. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway. Phytomedicine 2024; 124: 155285.
Altamirano-Barrera A, Barranco-Fragoso B, Méndez-Sánchez N. Management strategies for liver fibrosis. Annals of Hepatology 2017; 16(1): 48-56.
Aydın MM, Akçalı KC. Liver fibrosis. The Turkish Journal of Gastroenterology 2018; 29(1): 14-21.
Ramos-Tovar E, Muriel P. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver. Antioxidants (Basel) 2020; 9(12): 1279.
Wang T, Zhou X, Kuang G, et al. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fbrosis by upregulation of heme oxygenase-1 in mice. Journal of Pharmacy and Pharmacology 2021; 73(3): 338-346.
Xie N, Ma R, Wang L, et al. Effect of formononetin on glucose oxidase-induced oxidative stress in rat hepatic stellate cells. Chinese Journal of Tissue Engineering Research 2023; 27(33): 5309-5313.
Yuan Z, Meng JH, Shen XG, et al. Formononetin Mitigates Liver Fibrosis via Promoting Hepatic Stellate Cell Senescence and Inhibiting EZH2/YAP Axis. Journal of Agricultural and Food Chemistry 2024; 72(41): 22606-22620.
Li H, Li LL. Effects and mechanism of formononetin on acute lung injury and immune function in septic rats. Anatomy Research 2024; 46(03): 236-241.
Shi ZJ, Yuan SY, Shi LL, et al. Programmed cell death in spinal cord injury pathogenesis and therapy. Cell Proliferation 2021; 54(3): e12992.
Ouyang BS, Deng LL, Yang FY, et al. Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis. Materials Today Bio 2023; 20: 100643.
Zhao BT, Mao HY, Yao CX, et al. Influence of formononetin on lung tissue damage in rats with acute pulmo-nary embolism by regulating Nrf2/HO-1 signaling pathway. Journal of North Sichuan Medical College 2023; 38(12): 1592-1597.
Yuan WY, Li LQ, Chen YY, et al. Frontline Science: Two flavonoid compounds attenuate allergic asthma by regulating epithelial barrier via G protein-coupled estrogen receptor: Probing a possible target for allergic inflammation. Journal of Leucocyte Biology 2020; 108(1): 59-71.
Lambrecht BN, Hammad H. The immunology of asthma. Nature Immunology 2015; 16: 45-56.
Chen LC, Yang F. Study on the effect and mechanism of sodium formononetin-3'-sulfonate on OVA-induced asthma mice. Journal of Tianjin University of Traditional Chinese Medicine 2024; 43(05): 407-412.
Zhang L, Wu Q, Huang YY, et al. Formononetin ameliorates airway inflammation by suppressing ESR1/NLRP3/Caspase-1 signaling in asthma. Biomedicine & Pharmacotherapy 2023; 168: 115799.
Yi L, Cui J, Wang WQ, et al. Formononetin attenuates airway inflammation and oxidative stress in murine allergic asthma. Frontiers in Pharmacology 2020; 11: 533841.
Wang J, Sun Y, Chen L, et al. Advances in modern research of formononetin. Journal of Shanxi University of Chinese Medicine 2017; 18(05): 74-76+79.
Yatkin E, Daglioglu S. Evaluation of the estrogenic effects of dietary perinatal Trifolium pratense. Journal of Veterinary Science 2011; 12(2): 121-126.
Xing DX, Liu ZG, Xue CK, et al. Study on the estrogen-like effects of formononetin and its correlation with blood lipids. Chinese Journal of Gerontology 2009; 29(18): 2340-2342.
Ji XL, Yang CC, Huang L, et al. Formononetin Ameliorates LPS-Induced Endometrial Epithelial Cell Injury in Rats via TLR4/MyD88/NF-κB Signaling Pathway. Pharmacology and Clinics of Chinese Materia Medica 2024; 40(02): 62-67.
Park Y, Choo SP, Jung GS, et al. Formononetin Inhibits Progression of Endometriosis via Regulation of p27, pSTAT3, and Progesterone Receptor: In Vitro and In Vivo Studies. Nutrients 2023; 15(13): 3001.
Jain P, Nayse PG, Patil DJ, et al. The possible antioxidant capabilities of formononetin in guarding against streptozotocin-induced diabetic nephropathy in rats. Future Journal Of Pharmaceutical Sciences 2020; 6(1): 414-422.
Zhuang K, Jiang XY, Liu RB, et al. Formononetin activates the Nrf2/ARE signaling pathway via sirt1 to improve diabetic eenal fibrosis. Frontiers in Pharmacology 2020; 11: 616378.
Zhu BW, Ni YF, Gong Y, et al. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling. Life Sciences 2023; 315: 121331.
Zhou HY, Luo L, Chen YY, et al. Effects of Formononetin on Sepsis Induced Acute Kidney Injury in Rats by Regulating the SIRT1/PGC-1α Pathway. Guiding Journal of Traditional Chinese Medicine and Pharmacy 2022; 01: 6-11.
Cheng L. A preliminary study on the effect of formononetin on mouse parietal bone cell. Master’s Degree. Zhengzhou University: Zhengzhou, China, 2022.
Tian FX, Ding P, Zhou LL. Effect of Formononetin on Alleviating Inflammatory Injury of Chondrocytes via NF-κB Signaling Pathway. Herald of Medicine 2024; 43(11): 1728-1732.
Xu F. Effect of Ononin on IL-1β-induced Chondrocyte Matrix Metabolism and Inflammation by Downregulating the MAPK and NF-κB Pathways. Master’s Degree. Guangxi Medical University: Guangxi, China, 2022.
Zhong W, Feng LH, Tian W, et al. SMURF1 inhibits the Th17 and Th17. 1 polarization and improves the Treg/Th17 imbalance in systemic lupus erythematosus through the ubiquitination of RORγt. Molecular Immunology 2023; 157: 186-194.
Keller LE, Tait Wojno ED, Begum L, et al. T Helper 17–Like Regulatory T Cells in Equine Synovial Fluid Are Associated With Disease Severity of Naturally Occurring Posttraumatic Osteoarthritis. The American Journal of Sports Medicine 2023; 51(4): 1047-1058.
Bi B, Gou PG, Huang XH. Effects of formononetin on inflammatory response, cartilage damage and T helper cell 17/interleukin-26 inflammatory axis in rats with osteoarthritis. Chinese Journal of Experimental Surgery 2024; 41(1): 87-90.
Wang GZ, Liu HM, Liu Y, et al. Formononetin alleviates Streptococcus suis infection by targeting suilysin. Microbial Pathogenesis 2020; 147: 104388.
Yuan WY, Chen YY, Zhou YJ, et al. Formononetin attenuates atopic dermatitis by upregulating A20 expression via activation of G protein-coupled estrogen receptor. Journal of Ethnopharmacology 2021; 266: 113397.
Qiu GZ, Tian W, Huan M, et al. Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice. Experimental Biology and Medicine 2017; 242(2): 223-230.
Zhang CH, Hu LY, Xie Y, et al. Formononetin improves cognitive behavior in aging rats with chronic unpredictable mild in hippocampal tissue stress by blocking the NF-κB pathway and inhibiting the release of inflammatory factors. Chinese Journal of Cellular and Molecular Immunology 2023; 39(07): 610-616.
Tian YJ, Yang X, Wang J, et al. Influence of formononetin on oxidative stress injury in gestational diabetes mellitus rats. Tianjin Medical Journal 2023; 51(07): 734-739.
Huang JJ, Chen XF, Xie AH. Formononetin ameliorates IL13induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathway. Medicine Reports 2021; 24(6).
Cheng HL, Tao CL, Chen WD, et al. Research Progress on the Pharmacological Effects of Isoflavones from Trifolium pratense L. Journal of Anhui University of Chinese Medicine 2011; 04: 76-80.
Published
Data Availability Statement
The data presented in this study are available on request from the corresponding author.
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
